Financials data is unavailable for this security.
View more
Year on year Cryofocus Medtech Shanghai Co Ltd grew revenues 50.83% from 27.15m to 40.95m while net income improved from a loss of 112.22m to a smaller loss of 97.49m.
Gross margin | 76.35% |
---|---|
Net profit margin | -275.28% |
Operating margin | -273.46% |
Return on assets | -51.79% |
---|---|
Return on equity | -65.74% |
Return on investment | -66.30% |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at Cryofocus Medtech Shanghai Co Ltd fell by 123.02m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 95.89m for operations while cash used for investing totalled 15.10m.
Cash flow per share | -0.4775 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.5434 |
---|---|
Tangible book value per share | 0.5434 |
More ▼
Balance sheet in CNYView more
Current ratio | 2.53 |
---|---|
Quick ratio | 2.06 |
Total debt/total equity | 0.32 |
---|---|
Total debt/total capital | 0.2303 |
More ▼